EEI-BIOTECHFINANCES Eléments Essentiels d'Information / Essential Elements of Information
Wednesday, August 14th 2019 at 12:00pm UTC SAN JOSE, Calif.–(BUSINESS WIRE)– Accellix Inc. announces the appointment of a new Board Member, Mr. Charles Piazza. Charles (Chuck) Piazza, Accellix’s newest board member, has over 35 years of global experience within the life science industry serving the pharmaceutical, biotechnology and medical research …
Plus »Juvenescence Closes $100 Million Series B Round, Plans Follow on and Incremental Investments in Longevity Drug Development
Monday, August 19th 2019 at 6:00am UTC TORTOLA, British Virgin Islands–(BUSINESS WIRE)– Juvenescence, a life sciences company utilising expert drug developers and artificial intelligence experts to create therapeutics and technologies to treat diseases of aging and to increase human longevity, is pleased to announce the successful closure of its $100 …
Plus »NUS, Agilent, and NUH Launch New Translational R&D Hub to Boost Clinical Diagnostics
Monday, August 19th 2019 at 12:00pm UTC S$38 million research facility aims to be a premier, global, one-stop hub for research and translation to clinical testing through biochemical innovation and techniques SINGAPORE–(BUSINESS WIRE)– The National University of Singapore (NUS), Agilent Technologies, a global leader in life sciences, diagnostics, and applied …
Plus »Cyrus Biotechnology Significantly Expands Customer Engagement through Biotherapeutic Partnerships and Fee-for-Service Scientific Consulting
Thursday, August 15th 2019 at 10:24pm UTC SEATTLE–(BUSINESS WIRE)– Cyrus Biotechnology, Inc., a Seattle-based biotech software company specializing in the use and commercialization of Rosetta, the world’s leading computational protein design platform, announces a significant expansion of its efforts to leverage the full range of Rosetta’s capabilities to establish biotherapeutic …
Plus »Genomind Partners with NeuroFlow, Transforming Model of Care for Mental Health Patients
Monday, August 19th 2019 at 12:05pm UTC – Unique collaborative service combines innovative digital health platform and genetic testing to improve patient wellness and lower costs across the continuum of care for conditions including depression, anxiety, PTSD, and substance abuse – Software applications empower patient engagement and integrate synergistically with …
Plus »Agilent OFS Academy Receives Learning!100 Award for Third Consecutive Year
Monday, August 19th 2019 at 12:00pm UTC Company recognized for its efforts to develop employee talents SANTA CLARA, Calif.–(BUSINESS WIRE)– Agilent Technologies Inc. (NYSE: A) today announced it has received a Learning!100 Award from Elearning! Media Group (EMG). This is the third year in a row that EMG has recognized …
Plus »BioPharm International® Presents Webcasts on the Versatility of Light Scattering and the Exploration of Biotherapeutic Analysis
Wednesday, August 14th 2019 at 2:02pm UTC These separate webcasts will provide attendees with an improved understanding of the utility of dynamic light scattering and aggregate analysis and charge variant analysis using a native MS approach. CRANBURY, N.J.–(BUSINESS WIRE)– BioPharm International®, a digital resource of technical articles, technology reports, regulatory …
Plus »Kadiri Health Awarded Vizient’s Innovative Technology Contract for HELICOLL, Biological Skin Substitute
Friday, August 16th 2019 at 3:43pm UTC DAYTON, Ohio–(BUSINESS WIRE)– Kadiri Health LLC, a supplier of tissue regenerative technology products, announced its HELICOLL™ biological skin substitute product, has received an Innovative Technology contract from Vizient, Inc., the largest member-driven health care performance improvement company in the country. The contract was …
Plus »Q-State Biosciences and 2bPrecise Announce Partnership
Tuesday, August 13th 2019 at 12:01pm UTC Initiative designed to accelerate discovery of genetically targeted medicines and broaden options for enhanced patient care CAMBRIDGE, Mass., CHICAGO & PITTSBURGH–(BUSINESS WIRE)– Q-State Biosciences and 2bPrecise will partner to build robust clinical-genomic datasets enabling healthcare providers to better leverage precision medicine when treating …
Plus »ClinOne Makes a Big Push for Clinical Trial Sponsors to Communicate with Their Patients
Tuesday, August 13th 2019 at 1:02pm UTC DENVER–(BUSINESS WIRE)– ClinOne is pushing their sponsors to accelerate the frequency of their communication to clinical trial patients with their new offering. Communication is key to engagement and retention. ClinOne CEO Rob Bohacs states, “As a part of every clinical trial journey, patients …
Plus »
